Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
Formats
RDF:
N-Triples
N3
Turtle
JSON
XML
OData:
Atom
JSON
Microdata:
JSON
HTML
Embedded:
JSON
Turtle
Other:
CSV
JSON-LD
Faceted Browser
Sparql Endpoint
About:
Monoclonal antibodies
An Entity of Type:
Concept
,
from Named Graph:
http://dbpedia.org
,
within Data Space:
dbpedia.org
Property
Value
dbo:
wikiPageID
2004683
(xsd:integer)
dbo:
wikiPageRevisionID
977440620
(xsd:integer)
dbp:
wikiPageUsesTemplate
dbt
:Commons_category
dbt
:CatAutoTOC
dbt
:Cat_main
rdf:
type
skos
:Concept
rdfs:
label
Monoclonal antibodies
(en)
skos:
broader
dbc
:Therapeutic_antibodies
skos:
prefLabel
Monoclonal antibodies
(en)
prov:
wasDerivedFrom
wikipedia-en
:Category:Monoclonal_antibodies?oldid=977440620&ns=14
is
dbo:
wikiPageWikiLink
of
dbr
:Cambridge_Antibody_Technology
dbr
:Camrelizumab
dbr
:Canakinumab
dbr
:Cantuzumab_ravtansine
dbr
:Caplacizumab
dbr
:Casirivimab/imdevimab
dbr
:Quilizumab
dbr
:Roledumab
dbr
:Romosozumab
dbr
:Rontalizumab
dbr
:Rovelizumab
dbr
:Samalizumab
dbr
:Sarilumab
dbr
:Satralizumab
dbr
:Enoblituzumab
dbr
:Bebtelovimab
dbr
:Belimumab
dbr
:Benralizumab
dbr
:Bezlotoxumab
dbr
:Bimagrumab
dbr
:Bivatuzumab
dbr
:Brentuximab_vedotin
dbr
:Denosumab
dbr
:Ansuvimab
dbr
:Anti-CD19_immunotoxin
dbr
:Anti-CD3_monoclonal_antibody
dbr
:Antibody-oligonucleotide_conjugate
dbr
:Bi-specific_T-cell_engager
dbr
:Pateclizumab
dbr
:Perakizumab
dbr
:Pertuzumab
dbr
:Pexelizumab
dbr
:Reslizumab
dbr
:Risankizumab
dbr
:Robatumumab
dbr
:Ublituximab
dbr
:Ulocuplumab
dbr
:Urelumab
dbr
:Urtoxazumab
dbr
:Ustekinumab
dbr
:Vadastuximab_talirine
dbr
:Vapaliximab
dbr
:Varlilumab
dbr
:Vatelizumab
dbr
:Vedolizumab
dbr
:Veltuzumab
dbr
:Vepalimomab
dbr
:Visilizumab
dbr
:Donanemab
dbr
:Duvortuxizumab
dbr
:Letolizumab
dbr
:Ligelizumab
dbr
:Zolbetuximab
dbr
:Crenezumab
dbr
:Crizanlizumab
dbr
:Andecaliximab
dbr
:Maslimomab
dbr
:Mavrilimumab
dbr
:Ruplizumab
dbr
:Chemically_linked_Fab
dbr
:Rinucumab
dbr
:Trifunctional_antibody
dbr
:Refanezumab
dbr
:Single-domain_antibody
dbr
:Rabbit_hybridoma
dbr
:Cixutumumab
dbr
:Clenoliximab
dbr
:Eldelumab
dbr
:Elsilimomab
dbr
:Emactuzumab
dbr
:Emapalumab
dbr
:Emibetuzumab
dbr
:Emicizumab
dbr
:Enavatuzumab
dbr
:Enoticumab
dbr
:Ensituximab
dbr
:Eptinezumab
dbr
:Fremanezumab
dbr
:Fresolimumab
dbr
:Galcanezumab
dbr
:Galiximab
dbr
:Gantenerumab
dbr
:Gatipotuzumab
dbr
:Gevokizumab
dbr
:Girentuximab
dbr
:Golimumab
dbr
:Mogamulizumab
dbr
:Monalizumab
dbr
:Monoclonal_antibody
dbr
:Morolimumab
dbr
:Muromonab-CD3
dbr
:Namilumab
dbr
:Crotedumab
dbr
:Opicinumab
dbr
:Otilimab
dbr
:Anifrolumab
dbr
:Apolizumab
dbr
:Bentracimab
dbr
:Lecanemab
dbr
:Lemalesomab
dbr
:Lerdelimumab
dbr
:Libivirumab
dbr
:Lirentelimab
dbr
:Lokivetmab
dbr
:Lumiliximab
dbr
:Sifalimumab
dbr
:Siltuximab
dbr
:Simtuzumab
dbr
:Siplizumab
dbr
:Stamulumab
dbr
:Demcizumab
dbr
:ZMapp
dbr
:Zanolimumab
dbr
:Zolimomab_aritox
dbr
:Frunevetmab
dbr
:Ianalumab
dbr
:Ieramilimab
dbr
:Monoclonal_antibody_therapy
dbr
:Maftivimab
dbr
:Nomenclature_of_monoclonal_antibodies
dbr
:Bamlanivimab
dbr
:Brolucizumab
dbr
:Burosumab
dbr
:Cedelizumab
dbr
:Certolizumab_pegol
dbr
:Tigatuzumab
dbr
:Tildrakizumab
dbr
:Tislelizumab
dbr
:Tixagevimab/cilgavimab
dbr
:Tocilizumab
dbr
:Toralizumab
dbr
:Tositumomab
dbr
:Tralokinumab
dbr
:Tregalizumab
dbr
:Tremelimumab
dbr
:Tuvirumab
dbr
:GSK2831781
dbr
:Landogrozumab
dbr
:Mirikizumab
dbr
:Nirsevimab
dbr
:Abciximab
dbr
:Abituzumab
dbr
:Actoxumab
dbr
:Adalimumab
dbr
:Aducanumab
dbr
:Alacizumab_pegol
dbr
:Alirocumab
dbr
:Amatuximab
dbr
:Daclizumab
dbr
:Drozitumab
dbr
:Dupilumab
dbr
:Durvalumab
dbr
:Dusigitumab
dbr
:Ecromeximab
dbr
:Eculizumab
dbr
:Edobacomab
dbr
:Erenumab
dbr
:Erlizumab
dbr
:Etrolizumab
dbr
:Evinacumab
dbr
:Evolocumab
dbr
:Exbivirumab
dbr
:Faralimomab
dbr
:Faricimab
dbr
:Farletuzumab
dbr
:Fasinumab
dbr
:Felvizumab
dbr
:Ficlatuzumab
dbr
:Flanvotumab
dbr
:Fontolizumab
dbr
:Foralumab
dbr
:Foravirumab
dbr
:Bamlanivimab/etesevimab
dbr
:Brazikumab
dbr
:Brontictuzumab
dbr
:Otelixizumab
dbr
:Otlertuzumab
dbr
:Pagibaximab
dbr
:Palivizumab
dbr
:Panobacumab
dbr
:Pascolizumab
dbr
:Flotetuzumab
dbr
:Istiratumab
dbr
:Lenvervimab
dbr
:Lenzilumab
dbr
:Guselkumab
dbr
:Atoltivimab
dbr
:Itolizumab
dbr
:Ixekizumab
dbr
:Talizumab
dbr
:Tanezumab
dbr
:Technetium_(99mTc)_fanolesomab
dbr
:Tefibazumab
dbr
:Telimomab_aritox
dbr
:Tenatumomab
dbr
:Teneliximab
dbr
:Teplizumab
dbr
:Tezepelumab
dbr
:Aselizumab
dbr
:Atoltivimab/maftivimab/odesivimab
dbr
:Atorolimumab
dbr
:Abrilumab
dbr
:Abzyme
dbr
:Afucosylated_monoclonal_antibodies
dbr
:Keliximab
dbr
:Lampalizumab
dbr
:Lanadelumab
dbr
:Lebrikizumab
dbr
:Bimekizumab
dbr
:Bispecific_monoclonal_antibody
dbr
:Bleselumab
dbr
:Sutimlimab
dbr
:Suvizumab
dbr
:Tadocizumab
dbr
:Tafasitamab
dbr
:Regdanvimab
dbr
:Dinutuximab
dbr
:Diridavumab
dbr
:Domagrozumab
dbr
:Ascrinvacumab
dbr
:BIIB033
dbr
:CBR96-doxorubicin_immunoconjugate
dbr
:Pidilizumab
dbr
:Placulumab
dbr
:Solanezumab
dbr
:Solitomab
dbr
:Sotrovimab
dbr
:Spartalizumab
dbr
:Spesolimab
dbr
:HuMax
dbr
:Human_anti-mouse_antibody
dbr
:Humanized_antibody
dbr
:Ibalizumab
dbr
:Icrucumab
dbr
:Idarucizumab
dbr
:Inclacumab
dbr
:Inebilizumab
dbr
:Infliximab
dbr
:Inolimomab
dbr
:Mepolizumab
dbr
:Metelimumab
dbr
:Milatuzumab
dbr
:Narnatumab
dbr
:Natalizumab
dbr
:Nebacumab
dbr
:Nerelimomab
dbr
:Nesvacumab
dbr
:Obiltoxaximab
dbr
:Ocaratuzumab
dbr
:Ocrelizumab
dbr
:Odulimomab
dbr
:Olokizumab
dbr
:Omalizumab
dbr
:Onartuzumab
dbr
:Ontuxizumab
dbr
:Orticumab
dbr
:Cantuzumab
dbr
:Carotuximab
dbr
:Racotumomab
dbr
:Radretumab
dbr
:Rafivirumab
dbr
:Ralpancizumab
dbr
:Ramucirumab
dbr
:Ranibizumab
dbr
:Ravulizumab
dbr
:Raxibacumab
dbr
:Regavirumab
dbr
:Secukinumab
dbr
:Sevirumab
dbr
:Naxitamab
dbr
:Nemolizumab
dbr
:Neurovax
dbr
:Immune_stimulating_antibody_conjugate
dbr
:List_of_therapeutic_monoclonal_antibodies
dbr
:Lulizumab_pegol
dbr
:Lumretuzumab
dbr
:Lysibody
dbr
:Odesivimab
dbr
:Oleclumab
dbr
:Oligoclonal_antibody
dbr
:Plozalizumab
dbr
:Rosmantuzumab
dbr
:Trevogrumab
dbr
:Fletikumab
dbr
:TNF_inhibitor
dbr
:Vobarilizumab
dbr
:Tarextumab
dbr
:Single-chain_variable_fragment
dbr
:Theralizumab
dbr
:Pamrevlumab
dbr
:Seribantumab
dbr
:Small_modular_immunopharmaceutical
dbr
:Vanucizumab
dbr
:Suptavumab
dbr
:Suvratoxumab
is
dcterms:
subject
of
dbr
:Cambridge_Antibody_Technology
dbr
:Camrelizumab
dbr
:Canakinumab
dbr
:Cantuzumab_ravtansine
dbr
:Caplacizumab
dbr
:Casirivimab/imdevimab
dbr
:Quilizumab
dbr
:Roledumab
dbr
:Romosozumab
dbr
:Rontalizumab
dbr
:Rovelizumab
dbr
:Samalizumab
dbr
:Sarilumab
dbr
:Satralizumab
dbr
:Enoblituzumab
dbr
:Bebtelovimab
dbr
:Belimumab
dbr
:Benralizumab
dbr
:Bezlotoxumab
dbr
:Bimagrumab
dbr
:Bivatuzumab
dbr
:Brentuximab_vedotin
dbr
:Denosumab
dbr
:Ansuvimab
dbr
:Anti-CD19_immunotoxin
dbr
:Anti-CD3_monoclonal_antibody
dbr
:Antibody-oligonucleotide_conjugate
dbr
:Bi-specific_T-cell_engager
dbr
:Pateclizumab
dbr
:Perakizumab
dbr
:Pertuzumab
dbr
:Pexelizumab
dbr
:Reslizumab
dbr
:Risankizumab
dbr
:Robatumumab
dbr
:Ublituximab
dbr
:Ulocuplumab
dbr
:Urelumab
dbr
:Urtoxazumab
dbr
:Ustekinumab
dbr
:Vadastuximab_talirine
dbr
:Vapaliximab
dbr
:Varlilumab
dbr
:Vatelizumab
dbr
:Vedolizumab
dbr
:Veltuzumab
dbr
:Vepalimomab
dbr
:Visilizumab
dbr
:Donanemab
dbr
:Duvortuxizumab
dbr
:Letolizumab
dbr
:Ligelizumab
dbr
:Zolbetuximab
dbr
:Crenezumab
dbr
:Crizanlizumab
dbr
:Andecaliximab
dbr
:Maslimomab
dbr
:Mavrilimumab
dbr
:Ruplizumab
dbr
:Chemically_linked_Fab
dbr
:Rinucumab
dbr
:Trifunctional_antibody
dbr
:Refanezumab
dbr
:Single-domain_antibody
dbr
:Rabbit_hybridoma
dbr
:Cixutumumab
dbr
:Clenoliximab
dbr
:Eldelumab
dbr
:Elsilimomab
dbr
:Emactuzumab
dbr
:Emapalumab
dbr
:Emibetuzumab
dbr
:Emicizumab
dbr
:Enavatuzumab
dbr
:Enoticumab
dbr
:Ensituximab
dbr
:Eptinezumab
dbr
:Fremanezumab
dbr
:Fresolimumab
dbr
:Galcanezumab
dbr
:Galiximab
dbr
:Gantenerumab
dbr
:Gatipotuzumab
dbr
:Gevokizumab
dbr
:Girentuximab
dbr
:Golimumab
dbr
:Mogamulizumab
dbr
:Monalizumab
dbr
:Monoclonal_antibody
dbr
:Morolimumab
dbr
:Muromonab-CD3
dbr
:Namilumab
dbr
:Crotedumab
dbr
:Opicinumab
dbr
:Otilimab
dbr
:Anifrolumab
dbr
:Apolizumab
dbr
:Bentracimab
dbr
:Lecanemab
dbr
:Lemalesomab
dbr
:Lerdelimumab
dbr
:Libivirumab
dbr
:Lirentelimab
dbr
:Lokivetmab
dbr
:Lumiliximab
dbr
:Sifalimumab
dbr
:Siltuximab
dbr
:Simtuzumab
dbr
:Siplizumab
dbr
:Stamulumab
dbr
:Demcizumab
dbr
:ZMapp
dbr
:Zanolimumab
dbr
:Zolimomab_aritox
dbr
:Frunevetmab
dbr
:Ianalumab
dbr
:Ieramilimab
dbr
:Monoclonal_antibody_therapy
dbr
:Maftivimab
dbr
:Nomenclature_of_monoclonal_antibodies
dbr
:Bamlanivimab
dbr
:Brolucizumab
dbr
:Burosumab
dbr
:Cedelizumab
dbr
:Certolizumab_pegol
dbr
:Tigatuzumab
dbr
:Tildrakizumab
dbr
:Tislelizumab
dbr
:Tixagevimab/cilgavimab
dbr
:Tocilizumab
dbr
:Toralizumab
dbr
:Tositumomab
dbr
:Tralokinumab
dbr
:Tregalizumab
dbr
:Tremelimumab
dbr
:Tuvirumab
dbr
:GSK2831781
dbr
:Landogrozumab
dbr
:Mirikizumab
dbr
:Nirsevimab
dbr
:Abciximab
dbr
:Abituzumab
dbr
:Actoxumab
dbr
:Adalimumab
dbr
:Aducanumab
dbr
:Alacizumab_pegol
dbr
:Alirocumab
dbr
:Amatuximab
dbr
:Daclizumab
dbr
:Drozitumab
dbr
:Dupilumab
dbr
:Durvalumab
dbr
:Dusigitumab
dbr
:Ecromeximab
dbr
:Eculizumab
dbr
:Edobacomab
dbr
:Erenumab
dbr
:Erlizumab
dbr
:Etrolizumab
dbr
:Evinacumab
dbr
:Evolocumab
dbr
:Exbivirumab
dbr
:Faralimomab
dbr
:Faricimab
dbr
:Farletuzumab
dbr
:Fasinumab
dbr
:Felvizumab
dbr
:Ficlatuzumab
dbr
:Flanvotumab
dbr
:Fontolizumab
dbr
:Foralumab
dbr
:Foravirumab
dbr
:Bamlanivimab/etesevimab
dbr
:Brazikumab
dbr
:Brontictuzumab
dbr
:Otelixizumab
dbr
:Otlertuzumab
dbr
:Pagibaximab
dbr
:Palivizumab
dbr
:Panobacumab
dbr
:Pascolizumab
dbr
:Flotetuzumab
dbr
:Istiratumab
dbr
:Lenvervimab
dbr
:Lenzilumab
dbr
:Guselkumab
dbr
:Atoltivimab
dbr
:Itolizumab
dbr
:Ixekizumab
dbr
:Talizumab
dbr
:Tanezumab
dbr
:Technetium_(99mTc)_fanolesomab
dbr
:Tefibazumab
dbr
:Telimomab_aritox
dbr
:Tenatumomab
dbr
:Teneliximab
dbr
:Teplizumab
dbr
:Tezepelumab
dbr
:Aselizumab
dbr
:Atoltivimab/maftivimab/odesivimab
dbr
:Atorolimumab
dbr
:Abrilumab
dbr
:Abzyme
dbr
:Afucosylated_monoclonal_antibodies
dbr
:Keliximab
dbr
:Lampalizumab
dbr
:Lanadelumab
dbr
:Lebrikizumab
dbr
:Bimekizumab
dbr
:Bispecific_monoclonal_antibody
dbr
:Bleselumab
dbr
:Sutimlimab
dbr
:Suvizumab
dbr
:Tadocizumab
dbr
:Tafasitamab
dbr
:Regdanvimab
dbr
:Dinutuximab
dbr
:Diridavumab
dbr
:Domagrozumab
dbr
:Ascrinvacumab
dbr
:BIIB033
dbr
:CBR96-doxorubicin_immunoconjugate
dbr
:Pidilizumab
dbr
:Placulumab
dbr
:Solanezumab
dbr
:Solitomab
dbr
:Sotrovimab
dbr
:Spartalizumab
dbr
:Spesolimab
dbr
:HuMax
dbr
:Human_anti-mouse_antibody
dbr
:Humanized_antibody
dbr
:Ibalizumab
dbr
:Icrucumab
dbr
:Idarucizumab
dbr
:Inclacumab
dbr
:Inebilizumab
dbr
:Infliximab
dbr
:Inolimomab
dbr
:Mepolizumab
dbr
:Metelimumab
dbr
:Milatuzumab
dbr
:Narnatumab
dbr
:Natalizumab
dbr
:Nebacumab
dbr
:Nerelimomab
dbr
:Nesvacumab
dbr
:Obiltoxaximab
dbr
:Ocaratuzumab
dbr
:Ocrelizumab
dbr
:Odulimomab
dbr
:Olokizumab
dbr
:Omalizumab
dbr
:Onartuzumab
dbr
:Ontuxizumab
dbr
:Orticumab
dbr
:Cantuzumab
dbr
:Carotuximab
dbr
:Racotumomab
dbr
:Radretumab
dbr
:Rafivirumab
dbr
:Ralpancizumab
dbr
:Ramucirumab
dbr
:Ranibizumab
dbr
:Ravulizumab
dbr
:Raxibacumab
dbr
:Regavirumab
dbr
:Secukinumab
dbr
:Sevirumab
dbr
:Naxitamab
dbr
:Nemolizumab
dbr
:Neurovax
dbr
:Immune_stimulating_antibody_conjugate
dbr
:List_of_therapeutic_monoclonal_antibodies
dbr
:Lulizumab_pegol
dbr
:Lumretuzumab
dbr
:Lysibody
dbr
:Odesivimab
dbr
:Oleclumab
dbr
:Oligoclonal_antibody
dbr
:Plozalizumab
dbr
:Rosmantuzumab
dbr
:Trevogrumab
dbr
:Fletikumab
dbr
:TNF_inhibitor
dbr
:Vobarilizumab
dbr
:Tarextumab
dbr
:Single-chain_variable_fragment
dbr
:Theralizumab
dbr
:Pamrevlumab
dbr
:Seribantumab
dbr
:Small_modular_immunopharmaceutical
dbr
:Vanucizumab
dbr
:Suptavumab
dbr
:Suvratoxumab
is
skos:
broader
of
dbc
:Antibody-drug_conjugates
dbc
:Unnamed_monoclonal_antibodies
dbc
:Monoclonal_antibodies_for_tumors
This content was extracted from
Wikipedia
and is licensed under the
Creative Commons Attribution-ShareAlike 3.0 Unported License